|
ion transmembrane transport
|
GO:0034220 |
361 |
0.793
|
|
|
positive regulation of cholesterol storage
|
GO:0010886 |
3 |
0.772
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.733
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.690
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.682
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.516
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.508
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.491
|
|
|
cation transport
|
GO:0006812 |
399 |
0.477
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.472
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.420
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.391
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.386
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.377
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.368
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.361
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.347
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.342
|
|
|
alcohol catabolic process
|
GO:0046164 |
16 |
0.334
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.318
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.317
|
|
|
sodium ion export from cell
|
GO:0036376 |
1 |
0.315
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
15 |
0.313
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.312
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.300
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.299
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.294
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.292
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.291
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.288
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.271
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.266
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.264
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.254
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.253
|
|
|
regulation of lipid storage
|
GO:0010883 |
20 |
0.250
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.250
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.249
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.243
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.238
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.235
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.231
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.228
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.226
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.224
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.211
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.207
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.202
|
|
|
anion transport
|
GO:0006820 |
177 |
0.197
|
Mouse |
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.197
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.197
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.195
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.188
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.184
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.181
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.181
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.174
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.173
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.170
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.162
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.161
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.161
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.159
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.156
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.155
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.154
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.153
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.151
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.150
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.149
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.149
|
|
|
fatty acid transmembrane transport
|
GO:1902001 |
1 |
0.147
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.145
|
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.144
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.139
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.137
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.135
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.134
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.134
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.134
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.132
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.131
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.131
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.130
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.129
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.129
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.129
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.129
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.128
|
|
|
positive regulation of triglyceride metabolic process
|
GO:0090208 |
9 |
0.128
|
|
|
positive regulation of phagocytosis engulfment
|
GO:0060100 |
3 |
0.128
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.124
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.124
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.123
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.123
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.122
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.120
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.119
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.118
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.117
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.117
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.117
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.116
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.116
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.116
|
|
|
regionalization
|
GO:0003002 |
337 |
0.115
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.113
|
|
|
sodium ion export
|
GO:0071436 |
2 |
0.112
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.111
|
Mouse |
|
female sex differentiation
|
GO:0046660 |
84 |
0.110
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.109
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.109
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.109
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.109
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.108
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.106
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.104
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.103
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.103
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.101
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.101
|
|
|
gonad development
|
GO:0008406 |
141 |
0.100
|
|
|
renal system development
|
GO:0072001 |
225 |
0.099
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.097
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.097
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.096
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.096
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.095
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.095
|
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.095
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.095
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.095
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.094
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.094
|
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.093
|
|
|
plasma membrane long chain fatty acid transport
|
GO:0015911 |
1 |
0.092
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.089
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.088
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.088
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.088
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.087
|
|
|
kidney development
|
GO:0001822 |
213 |
0.087
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.086
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.085
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.085
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.084
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.084
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.084
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.084
|
|
|
protein import
|
GO:0017038 |
101 |
0.083
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.083
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.083
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.081
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.081
|
|
|
low density lipoprotein particle clearance
|
GO:0034383 |
8 |
0.081
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.080
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.080
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.080
|
|
|
response to fatty acid
|
GO:0070542 |
8 |
0.079
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.079
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.079
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.078
|
|
|
gland development
|
GO:0048732 |
330 |
0.078
|
|
|
cognition
|
GO:0050890 |
149 |
0.077
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.077
|
|
|
negative regulation of intracellular protein transport
|
GO:0090317 |
27 |
0.077
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.076
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.075
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.075
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.074
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.073
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.073
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.070
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.070
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.070
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.070
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.070
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.069
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.069
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.069
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.067
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.067
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.067
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.067
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.067
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.065
|
|
|
limb development
|
GO:0060173 |
166 |
0.065
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.064
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.062
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.062
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.062
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.062
|
|
|
protein targeting to vacuole
|
GO:0006623 |
3 |
0.061
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.061
|
|
|
regulation of phagocytosis engulfment
|
GO:0060099 |
5 |
0.061
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.061
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.060
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.060
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.060
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.060
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.060
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.060
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.059
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.059
|
Mouse |
|
potassium ion transport
|
GO:0006813 |
52 |
0.059
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.059
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.058
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.058
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.058
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.057
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.057
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.057
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.056
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.056
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.056
|
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
11 |
0.056
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.056
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.056
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.056
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.056
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.056
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.056
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.055
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.055
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.055
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.055
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.054
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.054
|
|
|
regulation of cholesterol storage
|
GO:0010885 |
4 |
0.054
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.054
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.053
|
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.053
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.053
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.053
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.052
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.052
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.052
|
|
|
negative regulation of protein localization to nucleus
|
GO:1900181 |
23 |
0.052
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.052
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.051
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.051
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.051
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.050
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.050
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.050
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.049
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.049
|
|
|
tube formation
|
GO:0035148 |
140 |
0.049
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.049
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.049
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.049
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.049
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.048
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.048
|
|
|
negative regulation of cytoplasmic transport
|
GO:1903650 |
29 |
0.048
|
|
|
mating behavior sex discrimination
|
GO:0048047 |
1 |
0.048
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.048
|
|
|
skin development
|
GO:0043588 |
220 |
0.048
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.048
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.048
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.047
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.047
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.046
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.045
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.045
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.045
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.045
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.044
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.043
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.043
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.043
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.043
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.043
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.042
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.042
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.042
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.042
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.042
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.042
|
|
|
lung development
|
GO:0030324 |
164 |
0.042
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.042
|
|
|
heart process
|
GO:0003015 |
94 |
0.042
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.042
|
|
|
response to activity
|
GO:0014823 |
13 |
0.042
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.041
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.041
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.041
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.041
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.041
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.041
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.041
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.041
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.040
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.040
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.040
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.040
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.040
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.040
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.039
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.039
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.039
|
|
|
learning
|
GO:0007612 |
98 |
0.039
|
|
|
neuron death
|
GO:0070997 |
154 |
0.039
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.038
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.038
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.038
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.038
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.038
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.038
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.038
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.037
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.037
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.037
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.037
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.037
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.037
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.037
|
|
|
muscular septum morphogenesis
|
GO:0003150 |
4 |
0.037
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.037
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.037
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.037
|
|
|
positive regulation of sequestering of triglyceride
|
GO:0010890 |
4 |
0.037
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.037
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.037
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.036
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.036
|
|
|
positive regulation of interleukin 6 production
|
GO:0032755 |
37 |
0.036
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.036
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.036
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.036
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.035
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.035
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.035
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.035
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.035
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.035
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.035
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.035
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.035
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.035
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.034
|
|
|
regulation of cardiac muscle contraction by calcium ion signaling
|
GO:0010882 |
9 |
0.034
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.034
|
|
|
sterol transmembrane transport
|
GO:0035382 |
2 |
0.034
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.034
|
|
|
negative regulation of protein import into nucleus
|
GO:0042308 |
21 |
0.034
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.034
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.034
|
|
|
spleen development
|
GO:0048536 |
39 |
0.034
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.034
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.033
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.033
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.033
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.033
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.033
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.033
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.033
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.033
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.032
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.032
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.032
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.032
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.032
|
|
|
establishment of protein localization to vacuole
|
GO:0072666 |
4 |
0.032
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.032
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.032
|
|
|
regulation of phospholipid catabolic process
|
GO:0060696 |
2 |
0.031
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.031
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.031
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.031
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.031
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.031
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.031
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.031
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.031
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.031
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.031
|
|
|
lipoprotein transport
|
GO:0042953 |
7 |
0.030
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.030
|
|
|
phospholipid transport
|
GO:0015914 |
21 |
0.030
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.030
|
|
|
regulation of sequestering of triglyceride
|
GO:0010889 |
6 |
0.030
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.030
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.030
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.030
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.030
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.030
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.030
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.030
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.030
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.030
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.030
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.030
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.030
|
|
|
positive regulation of sodium ion transport
|
GO:0010765 |
13 |
0.030
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.029
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.029
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.029
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.029
|
|
|
regulation of sodium ion transmembrane transporter activity
|
GO:2000649 |
9 |
0.029
|
|
|
negative regulation of nucleocytoplasmic transport
|
GO:0046823 |
23 |
0.029
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.029
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.029
|
|
|
associative learning
|
GO:0008306 |
61 |
0.029
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.029
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.029
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.028
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.028
|
|
|
response to bacterial lipopeptide
|
GO:0070339 |
3 |
0.028
|
|
|
cell growth
|
GO:0016049 |
130 |
0.028
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.028
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.028
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.028
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.028
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.028
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.028
|
|
|
directional locomotion
|
GO:0033058 |
3 |
0.028
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.028
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.028
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.028
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.027
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.027
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.027
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.027
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.027
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.027
|
|
|
ear development
|
GO:0043583 |
200 |
0.027
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.027
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.027
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.027
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.027
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.027
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.027
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.027
|
|
|
phospholipid catabolic process
|
GO:0009395 |
5 |
0.027
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.026
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.026
|
|
|
positive regulation of transmembrane transport
|
GO:0034764 |
29 |
0.026
|
|
|
appendage development
|
GO:0048736 |
166 |
0.026
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.026
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.026
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.026
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.026
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.026
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.026
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.026
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.026
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.026
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.026
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.026
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.026
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.026
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.026
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.026
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.026
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.026
|
|
|
columnar cuboidal epithelial cell maturation
|
GO:0002069 |
4 |
0.026
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.026
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.026
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.026
|
|
|
histone modification
|
GO:0016570 |
159 |
0.025
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
14 |
0.025
|
|
|
regulation of rac gtpase activity
|
GO:0032314 |
13 |
0.025
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.025
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.025
|
|
|
intestinal epithelial cell maturation
|
GO:0060574 |
2 |
0.025
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.025
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.025
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.025
|
|
|
calcium ion transport from endoplasmic reticulum to cytosol
|
GO:1903514 |
12 |
0.025
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.025
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.025
|
|
|
negative regulation of hepatocyte differentiation
|
GO:0070367 |
1 |
0.025
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.025
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.025
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.025
|
|
|
regulation of timing of cell differentiation
|
GO:0048505 |
11 |
0.025
|
|
|
nephron development
|
GO:0072006 |
109 |
0.025
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.025
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.025
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.025
|
|